Press Releases about Bourgine lab

Published 3 October 2022

Shortly after the great news that Paul Bourgine, associate senior lecturer in Molecular Skeletal Biology at the Wallenberg Centre for Molecular Medicine, Lund University, was awarded the ERC Proof of Concept grant, two new press-releases have been published in Dagens Medicin and News Cision acknowledging the great work and novel funding of a new confocal microscope for his research.

Paul Bourgine and his research group have developed a new technique for studying the origin and development of blood cancer.

"We look at what type of cells are involved and how the cancer cells grow. We can also test new drugs by injecting one into the piece of bone and then see if the cancer cells die or resist the treatment," says Paul Bourgine for News Cision.

Using their patented technology “OssiGel” to create human mini-bones, Paul Bourgine aims at using this technology to unravel processes of blood cancer formation, involvement of other cell types and envisions to test new anti-cancer drugs for acute myelogenous leukemia.

To achieve this goals, Paul Bourgine applied for funding of a new state-of-the-art confocal microscope, which has been granted by the Lundberg's Research Foundation with 3 million SEK.

“We applied for funding for a confocal microscope with the very latest technology. It is needed so that we can identify the different cells with certainty and where in the bone marrow they are located. In addition, the microscope facilitates the work of scanning in the information, it goes faster.” says Paul.

Now, with the new microscope, he and his group can perform sophisticated analysis of bone slices using up to 8 colours simultaneously.

Good luck with your research Paul!